News
Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...
Neuralink, the brain-chip startup founded by Elon Musk, announced the launch of their first clinical trial in the Middle East, UAE-PRIME, at Cleveland Clinic Abu Dhabi in partnership with the ...
Eli Lilly’s weight loss drug Zepbound outperformed competitor Novo Nordisk’s Wegovy, according to a clinical trial funded by Lilly. The SURMOUNT-5 trial, a Phase 3b open-label clinical trial ...
She'd been told she'd never walk again. Marta Carsteanu-Dombi is the most severely paralyzed patient who's enrolled in this clinical trial at NeuroRestore to regain mobility in her legs.
Achieving the same weight loss in day-to-day life as in the tightly controlled conditions of a clinical trial, while also using lower doses of drugs, has many potential benefits, from lower costs ...
The Food and Drug Administration's approval in 2023 of lecanemab—a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression—was met with enthusiasm by many in ...
4 Though the trials have not concluded, the clinical trial sponsors have already published their trial design methods, along with some promising interim results. 5 Models for success in Alzheimer ...
In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab infusions. The Food and Drug ...
The results of the MIROCALS randomized clinical trial have shown that adding low-dose interleukin-2 (IL2LD) to standard treatment for amyotrophic lateral sclerosis slowed functional decline and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results